Advances in rheumatoid arthritisDescription
Rheumatoid arthritis is a relatively common inflammatory arthritis and is self-reported by 2% of the Australian population.
This module summarises the literature on contemporary understanding of adult rheumatoid arthritis (RA) focusing on current therapy, especially biological therapy.
- List the eight approved biological disease-modifying antirheumatic drugs (bDMARDs), also in combination therapy with traditional DMARDs
- Recognise the potential of those therapeutic options with a realistic goal of remission, guiding patients in the process to lead a ‘normal life’
- Identify the ‘window opportunity’ that changes the long-term phenotype of the disease
RACGP: 2 pts
ACRRM - Fellow: 1 pt
ACRRM - Non Fellow: 1h : 0m